HHRI News & Press Releases
ASPREE-XT (eXTension) study receives $42.3 million to determine longer-term effects of aspirin on health
The ASPREE-XT (eXTension)* study was recently awarded $42.3 million in funding from the National Institute On Aging of the National Institutes of Health (NIH). The five-year grant enables researchers to study if there are possible long-term health benefits of being on low-dose aspirin. ASPREE-XT is led by the Berman Center…
Read More
ASPREE study – A Game Changer in Healthcare
The New England Journal of Medicine named the ASPirin in Reducing Events in the Elderly (ASPREE) study one of the 12 most notable articles in 2018 that had an impact on medicine. Led by Hennepin Healthcare Research Institute investigator Anne M. Murray, MD, MSc, in Minneapolis and John J. McNeil,…
Read More
Daily low-dose aspirin found to have no effect on healthy life span in older people
Large NIH-funded study examined outcomes in United States and Australia. In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability). Risk of…
Read More